What Factors May Impact the Likelihood of First Abbreviated New Drug Application (ANDA) Submission for a Reference Product?
May 1, 2018, 00:00 AM
10.1016/j.jval.2018.04.785
https://www.valueinhealthjournal.com/article/S1098-3015(18)31085-4/fulltext
Section Title :
Section Order :
103
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31085-4&doi=10.1016/j.jval.2018.04.785